Internal Medicine, Hematology & Oncology · Miami, FL
NPI
1366439689
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
8900 N Kendall Dr, Miami Cancer Institute
Miami, FL, 33176
Phone (786) 596-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$98K
1,758 services
Medicare patients, 2024
266
Average age 75
Drug cost, 2024
$4.8M
1,026 prescriptions
Company payments, 2025
$14K
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Federico Albrecht was code 99214 (office e&m - established), 819 times for 187 patients. In total Federico Albrecht billed 1,758 services in 11 codes, and Medicare paid $98K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-06-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 819 | 187 | $75.21 | $62K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 686 | 179 | $13.58 | $9,315 |
| 99215 Office E&M - Established | Facility | 104 | 67 | $119.96 | $12K |
| 99205 Office E&M - New | Facility | 40 | 40 | $150.60 | $6,024 |
| 99233 Hospital E&M - Subsequent | Facility | 34 | 32 | $99.53 | $3,384 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 13 | 13 | $26.44 | $344 |
By year: 2022 $84K for 989 services; 2023 $90K for 1,063 services; 2024 $98K for 1,758 services.
Medicare prescription drug claims, 2024
In 2024, the drug Federico Albrecht prescribed most often to Medicare patients was Tagrisso (Osimertinib Mesylate), with 146 prescriptions and refills. In total Federico Albrecht wrote 1,026 Medicare prescriptions that cost $4.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tagrisso Osimertinib Mesylate | 146 | 150 | 29 | $2.5M |
| Folic Acid Generic | 108 | 248 | 47 | $671 |
| Ondansetron Hcl Generic | 103 | 103 | 85 | $667 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 83 | 84 | 69 | $1,036 |
| Dexamethasone Generic | 81 | 83 | 67 | $1,137 |
| Prednisone Generic | 35 | 35 | 19 | $122 |
| Megestrol Acetate Generic | 31 | 34 | 21 | $3,024 |
| Eliquis Apixaban | 30 | 36 | 16 | $21K |
| Gilotrif Afatinib Dimaleate | 25 | 29 | Under 11 | $330K |
| Alecensa Alectinib Hcl | 22 | 23 | Under 11 | $414K |
| Pantoprazole Sodium Generic | 18 | 38 | 11 | $519 |
| Levothyroxine Sodium Generic | 17 | 26 | Under 11 | $33.38 |
| Tramadol Hcl Generic | 17 | 17 | 11 | $62.31 |
| Ciclopirox Ciclopirox Olamine | 15 | 15 | Under 11 | $144 |
| Lorbrena Lorlatinib | 15 | 15 | Under 11 | $297K |
Brand drugs: 333 claims; generic drugs: 693 claims; opioid claims: 53.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Federico Albrecht $14K ($14K in general payments such as food, travel and fees) from 13 companies. The largest payer was Jazz Pharmaceuticals Inc. with $8,409.
| Company | Payments | Amount |
|---|---|---|
| Jazz Pharmaceuticals Inc. JAZZ | 10 | $8,409 |
| Partner Therapeutics, Inc. | 9 | $3,320 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $1,419 |
| E.R. Squibb & Sons, L.L.C. BMY | 8 | $439 |
| AstraZeneca Pharmaceuticals LP AZN | 9 | $403 |
| Janssen Biotech, Inc. JNJ | 2 | $142 |
| Nuvation Bio Inc. NUVB | 1 | $75.57 |
| Daiichi Sankyo Inc. 4568.T | 2 | $54.7 |
| Array Biopharma Inc PFE | 2 | $53.23 |
| Merck Sharp & Dohme LLC MRK | 2 | $52.67 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.